Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Drivers in Serrated Pathway-Driven Colorectal Cancer Progression
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252010944 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jiahui Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Single-Cell Analysis, Disease Progression, Tumor Microenvironment. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Serrated lesions are common precancerous pathways in colorectal cancer (CRC), but the process by which they progress to malignancy remains unclear. We aimed to elucidate this progression through a single-cell RNA landscape. We conducted single-cell RNA sequencing on three normal colonic tissues and fifteen SLs (including HPs, SSLs, SSLD, and TSAs) and integrated these data with datasets containing tumor samples. We identified three invasive malignant epithelial cell subtypes related to CRC progression: SLC1, SLC2, and tumor cell. SLC1, specific to SSLs, is involved in cell proliferation and shows a continuum of malignancy in gene expression. TSA-specific SLC2 exhibited FOXQ1 upregulation and active EMT, indicating invasiveness. The trajectory analysis showed that HPs do not progress to cancer, and different SL types are linked to the MSI status of advanced CRCs. We validated molecular drivers in premalignant lesions and later carcinogenesis. In the tumor microenvironment, CAF and pre-CAF fibroblast subtypes associated with progression were identified. During the premalignant stage, SLC1 triggered CD8+ T cell responses, while at the advanced stage, CAFs promoted tumor invasion and metastasis via FN1-CD44, influencing tumor progression and the treatment response. Our findings highlight transcriptional changes across serrated pathway stages, aiding in early CRC diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Science, China Pharmaceutical University, Nanjing 211198, China.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Zhang, Y., Chen, X., Sheng, Q., Yang, J., Zhu, Y., Wang, Y., Yan, F., & Fang, J. (2024). Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Drivers in Serrated Pathway-Driven Colorectal Cancer Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010944
Vancouver
Wang J, Zhang Y, Chen X, Sheng Q, Yang J, Zhu Y, et al. Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Drivers in Serrated Pathway-Driven Colorectal Cancer Progression. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010944
BibTeX
@article{Wang2024,
author = {Wang, Jiahui and Zhang, Yu and Chen, Xinyi and Sheng, Qi and Yang, Junluo and Zhu, Yuyao and Wang, Yuhang and Yan, Fangrong and Fang, Jingya},
title = {Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Drivers in Serrated Pathway-Driven Colorectal Cancer Progression},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252010944}
}
EUVIMED